Swiss Life Asset Management’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.5M Sell
290,208
-90,456
-24% -$4.18M 0.06% 250
2026
Q1
$18.7M Buy
380,664
+11,368
+3% +$529K 0.09% 175
2025
Q4
$16.1M Buy
369,296
+136,347
+59% +$6.22M 0.08% 185
2025
Q3
$10.5M Sell
232,949
-125,234
-35% -$5.5M 0.05% 262
2025
Q2
$15.6M Buy
358,183
+86,906
+32% +$3.87M 0.09% 170
2025
Q1
$12.5M Buy
271,277
+125,227
+86% +$5.23M 0.09% 176
2024
Q4
$5.49M Buy
146,050
+81,312
+126% +$3.15M 0.04% 298
2024
Q3
$2.62M Sell
64,738
-38,421
-37% -$1.44M 0.03% 338
2024
Q2
$3.57M Buy
103,159
+1,060
+1% +$39.1K 0.04% 305
2024
Q1
$3.84M Sell
102,099
-119,612
-54% -$4.27M 0.05% 265
2023
Q4
$7.97M Buy
221,711
+62,576
+39% +$2.41M 0.1% 243
2023
Q3
$6.01M Buy
159,135
+49,297
+45% +$2.01M 0.09% 254
2023
Q2
$4.48M Sell
109,838
-182
-0.2% -$7.52K 0.07% 333
2023
Q1
$4.61M Buy
110,020
+43,945
+67% +$1.83M 0.07% 328
2022
Q4
$2.86M Sell
66,075
-145,604
-69% -$5.75M 0.05% 383
2022
Q3
$7.93M Sell
211,679
-7,666
-3% -$339K 0.14% 183
2022
Q2
$9.95M Buy
219,345
+105,980
+93% +$4.98M 0.16% 157
2022
Q1
$5.4M Sell
113,365
-54,923
-33% -$2.33M 0.08% 276
2021
Q4
$6.93M Sell
168,288
-55,000
-25% -$2.07M 0.09% 258
2021
Q3
$7.7M Buy
223,288
+25,720
+13% +$879K 0.11% 220
2021
Q2
$6.02M Buy
197,568
+52,890
+37% +$1.7M 0.06% 289
2021
Q1
$4.51M Buy
144,678
+2,515
+2% +$75.6K 0.06% 325
2020
Q4
$4.28M Buy
142,163
+107,977
+316% +$3.19M 0.06% 315
2020
Q3
$872K Sell
34,186
-63,644
-65% -$1.69M 0.01% 381
2020
Q2
$2.53M Buy
97,830
+79,640
+438% +$2.11M 0.04% 292
2020
Q1
$478K Sell
18,190
-772
-4% -$24.3K 0.01% 426
2019
Q4
$617K Sell
18,962
-9,887
-34% -$320K 0.01% 423
2019
Q3
$994K Sell
28,849
-140,699
-83% -$4.72M 0.01% 398
2019
Q2
$5.79M Buy
169,548
+17,613
+12% +$622K 0.07% 169
2019
Q1
$5.43M Buy
+151,935
New +$5.17M 0.07% 177
2018
Q4
Sell
-137,655
Closed -$4.29M 286
2018
Q3
$4.29M Sell
137,655
-45,530
-25% -$1.4M 0.06% 210
2018
Q2
$5.57M Buy
183,185
+57,277
+45% +$1.64M 0.08% 169
2018
Q1
$3.5M Buy
125,908
+65,287
+108% +$1.76M 0.06% 222
2017
Q4
$1.7M Sell
60,621
-34,590
-36% -$994K 0.04% 243
2017
Q3
$2.56M Buy
95,211
+42,462
+80% +$1.14M 0.07% 177
2017
Q2
$1.36M Buy
52,749
+6,419
+14% +$163K 0.03% 248
2017
Q1
$1.19M Buy
+46,330
New +$1.18M 0.03% 242
2016
Q4
Sell
-17,765
Closed -$422K 442
2016
Q3
$422K Buy
+17,765
New +$446K 0.01% 382

Other funds holding EXC

Swiss Life Asset Management's EXC Position: Q2 2026 in Review

Swiss Life Asset Management reduced its Exelon (EXC) stake by 24% in Q2 2026, selling an estimated $4.18M and leaving 290,208 shares worth $13.5M. The position accounts for 0.06% of the portfolio, ranked #250.

Swiss Life Asset Management first reported a position in EXC in Q3 2016 and has held it in 38 quarters since. The position peaked at $18.7M in Q1 2026. 912 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Swiss Life Asset Management held 290,208 shares of Exelon worth $13.5M as of Q2 2026.
  • Swiss Life Asset Management sold 90,456 Exelon shares in Q2 2026, an estimated $4.18M.
  • Exelon made up 0.06% of Swiss Life Asset Management's portfolio in Q2 2026, its #250 holding.
  • Swiss Life Asset Management first reported a position in Exelon in Q3 2016 and has held it in 38 quarters since.
  • Swiss Life Asset Management's Exelon position peaked at $18.7M in Q1 2026.
  • 912 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.